Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flumazenil Reversal of Oral Triazolam
NCT00695630Phase 2Completed
- Sponsor
- University of Washington
- Start
- Sep 2006
- Primary completion
- Dec 2007
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of flumazenil, sponsored by University of Washington. Started Sep 2006; status: completed.
02
Drugs
flumazenil
Beyond the preview
Go deeper on NCT00695630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00695630.